资讯

Drug Delivery Business

Dexcom to unveil new basal insulin titration module under FDA review, reports positive CGM data

Dexcom (Nasdaq:DXCM) today announced plans to unveil its Smart Basal integrated titration module for insulin delivery.
Drug Delivery Business

FDA identifies serious recall for Dexcom CGM mobile apps

The FDA identified a recall of smartphone apps for Dexcom (Nasdaq:DXCM) continuous glucose monitors as the most serious type.
Drug Delivery Business

BD expands Alaris recall after identifying new potential issue

BD (NYSE:BDX) announced that it expanded its Class I voluntary recall for its Alaris Pump Module model 8100 infusion system.